Skip to main content
Sunday, November 15, 2026Nov 15

A drug offers hope amid spikes in coronavirus infections

People wearing face masks to protect against the spread of coronavirus, walk in the main Kizilay Square, in Ankara, Turkey, Tuesday, June 16, 2020. Turkey has made the wearing of face masks mandatory in five more provinces, following an uptick in COVID-19 cases. Health Minister Fahrettin Koca tweeted early Tuesday that the wearing of masks is now compulsory in 42 of Turkey's 81 provinces.(AP Photo/Burhan Ozbilici)
People wearing face masks to protect against the spread of coronavirus, walk in the main Kizilay Square, in Ankara, Turkey, Tuesday, June 16, 2020. Turkey has made the wearing of face masks mandatory in five more provinces, following an uptick in COVID-19 cases. Health Minister Fahrettin Koca tweeted early Tuesday that the wearing of masks is now compulsory in 42 of Turkey's 81 provinces.(AP Photo/Burhan Ozbilici)

ATLANTA (AP) – As nations grapple with new outbreaks and spiking death tolls from the coronavirus, a commonly available drug appeared Tuesday to offer hope that the most seriously ill could have a better chance of survival.

The pandemic has forced countries to impose lockdowns and tough restrictions on daily life and travel, but infections have surged as they eased these rules and reopened their economies. With no vaccine available and much still unknown about the virus, researchers in England announced the first drug shown to save lives.

The drug, called dexamethasone, reduced deaths by 35% in patients who needed treatment with breathing machines and by 20% in those only needing supplemental oxygen, researchers in England said. It did not appear to help less ill patients.

British Prime Minister Boris Johnson said the drug was the “biggest breakthrough yet” in treating the coronavirus, and top U.S. infectious disease expert Dr. Anthony Fauci called it “a significant improvement in the available therapeutic options that we have.”

Britain is making dexamethasone available to patients on the country’s National Health Service. The U.K. Department of Health said the drug had been approved to treat all hospitalized COVID-19 patients requiring oxygen, effective immediately. It said the U.K. had stockpiled enough to treat 200,000 patients.